Amanote Research
Register
Sign In
Discovery of 3Oxabicyclo[4.1.0]heptane a Non-Nitrogen Containing Morpholine Isostere, and Its Application in Novel Inhibitors of the PI3K-AKT-mTOR Pathway
doi 10.1021/acs.jmedchem.9b00348.s001
Full Text
Open PDF
Abstract
Available in
full text
Date
Unknown
Authors
Unknown
Publisher
American Chemical Society (ACS)
Related search
Status of PI3K/Akt/mTOR Pathway Inhibitors in Lymphoma
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Development of PI3K/AKT/mTOR Pathway Inhibitors and Their Application in Personalized Therapy for Non–Small-Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Picking the Point of Inhibition: A Comparative Review of PI3K/AKT/mTOR Pathway Inhibitors
Molecular Cancer Therapeutics
Cancer Research
Oncology
Novel Expression Patterns of PI3K/Akt/mTOR Signaling Pathway Components in Colorectal Cancer
Journal of the American College of Surgeons
Surgery
Urolithin A, a Novel Natural Compound to Target PI3K/AKT/mTOR Pathway in Pancreatic Cancer
Molecular Cancer Therapeutics
Cancer Research
Oncology
Novel Obscurins Mediate Cardiomyocyte Adhesion and Size via the PI3K/AKT/mTOR Signaling Pathway
Journal of Molecular and Cellular Cardiology
Cardiovascular Medicine
Molecular Biology
Cardiology
Targeting the PI3K/Akt/mTOR Signalling Pathway in Cystic Fibrosis
Scientific Reports
Multidisciplinary
Targeting the PI3K/AKT/MTOR Pathway in KSHV-associated Cancers
Infectious Agents and Cancer
Cancer Research
Epidemiology
Oncology
Infectious Diseases
The Expression of the PI3K/AKT/mTOR Pathway in Gastric Cancer and Its Role in Gastric Cancer Prognosis
OncoTargets and Therapy
Oncology
Pharmacology
